Patent ID: 11903950
Assignee: NEWAVE PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 17:
18. The compound according to claim 15, or the N-oxide thereof, or the pharmaceutically acceptable salt, solvate, polymorph, tautomer, stereoisomer, or an isotopic form thereof, wherein R9 is, , wherein
Zb′ is a bond, (CH2)p, N(H), O, S, C(O), S(O)2, OC(O), C(O)O, OSO2, S(O)2O, C(O)S, SC(O), C(O)C(O), C(O)N(H), N(H)C(O), S(O)2N(H), N(H)S(O)2, OC(O)O, OC(O)S, OC(O)N(H), N(H)C(O)O, N(H)C(O)S, N(H)C(O)N(H), (CH2)pN(H)(CH2)q, (CH2)pN(H)C(O)(CH2)q, (CH2)pC(O)N(H)(CH2)q, OC(O)N(H)(CH2)p+1N(H)(CH2)q, a bivalent alkenyl group, or a bivalent alkynyl group.